Accretion Pharmaceuticals Alters Memorandum of Association Object Clause Following Shareholder Approval
Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 11 Oct 2026, 12:23 am
Accretion Pharmaceuticals Alters Memorandum of Association Object Clause Following Shareholder Approval Accretion Pharmaceuticals Limited received shareholder approval via postal ballot on 9th Oct'26 to alter Clause III (Object Clause) of its Memorandum of Association. The approved amendment substitutes Main Object Clause III(A) and inserts new sub-clauses numbered III(B)(10) through III(B)(47). The expanded mandate broadly covers manufacturing, trading, research, and distribution across pharmaceuticals, nutraceuticals, medical devices, healthcare facilities, diagnostic centers, clinical research organizations, consumer food items, and global strategic investments.
Original exchange filing (PDF)
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report. 路 12 Oct 2026
